Sundin A - Search Results

1

Dogra P, Sundin A, Juhlin CC, Calissendorff J, Falhammar H, Bancos I. Dogra P, et al. Among authors: sundin a. Eur J Endocrinol. 2023 Apr 5;188(4):407-420. doi: 10.1093/ejendo/lvad036. Eur J Endocrinol. 2023. PMID: 36943310 Review.

2

Positron emission tomography with 11C-methionine in hyperparathyroidism.

Hellman P, Ahlström H, Bergström M, Sundin A, Långström B, Westerberg G, Juhlin C, Akerström G, Rastad J. Hellman P, et al. Among authors: sundin a. Surgery. 1994 Dec;116(6):974-81. Surgery. 1994. PMID: 7985105

3

[Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].

Juhlin C, Törnblom S, Rastad J, Bergström M, Bonasera T, Sundin A, Långström B. Juhlin C, et al. Among authors: sundin a. Nord Med. 1998 Nov;113(9):306-7. Nord Med. 1998. PMID: 9835764 Swedish.

4

PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.

Bergström M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerström G, Långström B. Bergström M, et al. Among authors: sundin a. J Nucl Med. 2000 Feb;41(2):275-82. J Nucl Med. 2000. PMID: 10688111 Free article.

5

The role of PET in localization of neuroendocrine and adrenocortical tumors.

Eriksson B, Bergström M, Sundin A, Juhlin C, Orlefors H, Oberg K, Långström B. Eriksson B, et al. Among authors: sundin a. Ann N Y Acad Sci. 2002 Sep;970:159-69. doi: 10.1111/j.1749-6632.2002.tb04422.x. Ann N Y Acad Sci. 2002. PMID: 12381551 Review.

6

11C-metomidate PET imaging of adrenocortical cancer.

Khan TS, Sundin A, Juhlin C, Långström B, Bergström M, Eriksson B. Khan TS, et al. Among authors: sundin a. Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):403-10. doi: 10.1007/s00259-002-1025-9. Epub 2002 Dec 20. Eur J Nucl Med Mol Imaging. 2003. PMID: 12634969 Clinical Trial.

7

An unusual case of tumor thrombus in the inferior vena cava. A case report.

Radecka E, Brekkan E, Juhlin C, Nilsson L, Sundin A, Magnusson A. Radecka E, et al. Among authors: sundin a. Acta Radiol. 2003 Mar;44(2):160-1. doi: 10.1080/j.1600-0455.2003.00027.x. Acta Radiol. 2003. PMID: 12694101

8

PET with [11C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions.

Bergström M, Sörensen J, Kahn TS, Juhlin C, Eriksson B, Sundin A, Bonasera TA, Fasth K, Långström B. Bergström M, et al. Among authors: sundin a. Clin Positron Imaging. 1999 Nov;2(6):339. doi: 10.1016/s1095-0397(99)00099-0. Clin Positron Imaging. 1999. PMID: 14516636 No abstract available.

9

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.

Khan TS, Sundin A, Juhlin C, Wilander E, Oberg K, Eriksson B. Khan TS, et al. Among authors: sundin a. Med Oncol. 2004;21(2):167-77. doi: 10.1385/MO:21:2:167. Med Oncol. 2004. PMID: 15299189 Clinical Trial.

10

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.

Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, Langstrom B, Bergstrom M, Eriksson B. Orlefors H, et al. Among authors: sundin a. J Clin Endocrinol Metab. 2005 Jun;90(6):3392-400. doi: 10.1210/jc.2004-1938. Epub 2005 Mar 8. J Clin Endocrinol Metab. 2005. PMID: 15755858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters